510(k) · Cleared
Recalled · 2007Binaxnow Influenza a & B Test
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Binax, Inc. · PSZ Devices Detecting Influenza A, B, And C Virus Antigens
Cleared on Nov 9, 2006 as substantially equivalent to K001364 (Bd Becton Dickinson Vacutainer Systems Preanalytic, 2000) after a 108-day review. Its family tree reaches back 1 generation to 2000. 8 later devices descend from it. It has been recalled 2 times.
- Decided
- Nov 9, 2006
- Review
- 108 days
- Class
- Class II
- Product code
- PSZ
- Recalls
- 2
- Predicates
- 1
Its longest line of descent runs back 1 generation to K001364 (2000). 8 later devices descend from it, 4 citing it directly.
- Root · 1 generation backK001364 BD Directigen Flu a+BBd Becton Dickinson Vacutainer Systems Preanalytic · 2000
- This deviceK062109 Binaxnow Influenza a & B TestBinax, Inc. · 2006
- Descendant · cites it directly · 2 of its ownK092349 Clearview Exact II Influenza a & B TestInverness Medical, Inc. · 2010
- Descendant · 2 generations on · 1 of its ownK103610 Clearview Exact II Influenza a & B TestAlere Scarborough, Inc D/B/A Binax, Inc. · 2011
- Descendant · cites it directly · 1 of its ownK092223 Modification to: Binaxnow Influenza a & B TestBinax, Inc. · 2009
- Descendant · cites it directly · 1 of its ownK071591 Ramp Influenza a/B AssayResponse Biomedical Corp. · 2008
- Descendant · 3 generations on · 0 of its ownK133637 Alere Influenza a & B TestAlere Scarborough, Inc D/B/A Binax, Inc. · 2013
Showing 5 of 8 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 8 · See all- K092349Clearview Exact II Influenza a & B TestInverness Medical, Inc. · 2010 · cites it directly2descendants
- K103610Clearview Exact II Influenza a & B TestAlere Scarborough, Inc D/B/A Binax, Inc. · 2011 · 2 generations on1descendant
- K092223Modification to: Binaxnow Influenza a & B TestBinax, Inc. · 2009 · cites it directly1descendant
- K071591Ramp Influenza a/B AssayResponse Biomedical Corp. · 2008 · cites it directly1descendant
- K133637Alere Influenza a & B TestAlere Scarborough, Inc D/B/A Binax, Inc. · 2013 · 3 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K001364 | BD Directigen Flu a+B | Bd Becton Dickinson Vacutainer Systems Preanalytic | 2000 | — |
| 0 (this device) | K062109 | Binaxnow Influenza a & B Test | Binax, Inc. | 2006 | — |
| +1 | K092349 | Clearview Exact II Influenza a & B Test | Inverness Medical, Inc. | 2010 | — |
| +2 | K103610 | Clearview Exact II Influenza a & B Test | Alere Scarborough, Inc D/B/A Binax, Inc. | 2011 | — |
| +1 | K092223 | Modification to: Binaxnow Influenza a & B Test | Binax, Inc. | 2009 | — |
| +1 | K071591 | Ramp Influenza a/B Assay | Response Biomedical Corp. | 2008 | — |
| +3 | K133637 | Alere Influenza a & B Test | Alere Scarborough, Inc D/B/A Binax, Inc. | 2013 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2009 | 2 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2013 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in PSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new PSZ device
- #1 K252283 Nano-Check Influenza A+B Testscore 14.9 · 15 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K001364 | BD Directigen Flu a+BSummary page 1…510(k) #K041049). To establish substantial equivalence to the predicate, the BinaxNOW® Influenza A & B Test was compared to the BD Directigen TM Flu A+B Test (510(k) # K001 364). SUBMITTER Binax, Inc., d/b/a Inverness Medical Professional Diagnostics 10 Southgate Road Scarborough, Maine 04074 (207) 730-5… | 2000 |
What descends from it? (8)
4 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Mar 28, 2007 | Not classified | Z-0822-2007 | Other | Tip of the foam swab could detach from the shaft causing injury to the patient. |
| Mar 28, 2007 | Not classified | Z-0823-2007 | Other | Tip of the foam swab could detach from the shaft causing injury to the patient. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All PSZ devicesPSZ Devices Detecting Influenza A, B, And C Virus Antigens: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · PSZ
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · PSZ
28in 2018
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · PSZ
1in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · PSZ
60in 2025
MAUDE reports naming product code PSZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 0 |
| 2008 | 1 | — | 0 | 0 |
| 2009 | 7 | 20 | 0 | 0 |
| 2010 | 5 | 29 | 0 | 0 |
| 2011 | 3 | 80 | 0 | 0 |
| 2012 | 2 | — | 0 | 0 |
| 2013 | 8 | 28 | 0 | 0 |
| 2014 | 1 | — | 0 | 0 |
| 2015 | 4 | 27 | 0 | 0 |
| 2016 | 3 | 29 | 0 | 0 |
| 2017 | 3 | 200 | 0 | 0 |
| 2018 | 5 | 28 | 0 | 1 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 2 | — | 1 | 5 |
| 2021 | 0 | — | 0 | 42 |
| 2022 | 0 | — | 1 | 10 |
| 2023 | 2 | — | 0 | 12 |
| 2024 | 0 | — | 0 | 16 |
| 2025 | 2 | — | 0 | 60 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
The BinaxNOW® Influenza A & B Test is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab, nasal swab, and nasal wash/aspirate specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decision.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K062109 · printed Nov 6, 2026
Cite this page
510(k) Report. “K062109: Binaxnow Influenza a & B Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K062109
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026